Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over the United States' request for sensitive biological samples.
This move came to light following a government memo dated December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official representative later explained that the US was demanding access to biological samples for scientific study and commercial gain while was not willing to share the benefits from future vaccines.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more negotiations to reach a deal suitable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Background
This rejection comes after a similar situation in Kenya, where a court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and responsibility.
As per statements, Sixteen nations in Africa have to date agreed to these new agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment via US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to share its biological resources and data for a long time, without any corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that might be developed from that provided information," he stated.
"Effectively, our country would supply the basic resources for medical research with no certainty that the final treatments would be available to our citizens should a future pandemic emerge."
National Interest and Global Health
He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems previously established via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage future pandemics.
"This system is designed to guarantee that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage further discussions with our American counterparts on how future co-operation could be arranged in a way that respects the sovereignty and interests of both nations."
Medical Community Response
Medical experts expressed it understood the official position, but suggested that negotiations need to persist given that much of the country's Aids initiatives depended on external financing.
"If technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," the group added.
The situation highlights the ongoing debate between receiving vital international aid and safeguarding local interests in an ever more interconnected world.